SRCC Children’s Hospital organizes mega awareness campaign on Rett Syndrome - Reliance Nippon Life Asset Management Limited’s – Initial Public Offer to open on Wednesday, October 25, 2017, and close on Friday, October 27, 2017 Price Band of Rs. 247 to Rs. 252 per Equity Share each of Face Value of Rs. 10/- each - Nomination process for the 6th Shriram Awards for Excellence in Financial Journalism begins - IIFL’S ‘DHAN KI BAAT’ INITIATIVE TO REACH 5 CRORE PEOPLE BY END OF 2018 - Delta Corp's 'Deltin World Gaming Festival 2017' Woos Gamers Across The World To Descend On Goa To Experience ‘A Celebration of a Lifetime‘ - GNC strengthens its presence in India - Camlin & ‘Aamchi Dilli’ to host art competition for kids on Shivaji Maharaj - LEAP India has emerged as leading player in Indian Pallets and FLC Pooling Market with Lions market Share - MUMBAI, NEW DELHI AND BENGALURU ARE HOME TO 73% REAL ESTATE BARRONS: GROHE HURUN INDIA REAL ESTATE RICH LIST 2017 - LATEST TRENDS IN NON- FERROUS METAL INDUSTRY - Seven Islands Shipping Limited files IPO papers with SEBI - General Insurance Corporation of India’s initial public offering to open on October 11, 2017, with a Price Band of ₹ 855 to₹ 912 per Equity Share, each of Face Value of ₹ 5 each - Indian Energy Exchange Limited’s Initial Public Offer to open on Monday, October 9, 2017 and to close on Wednesday, October 11, 2017 Price Band fixed from Rs. 1,645 to Rs. 1,650 per Equity Share - MAS Financial Services Limited’s IPO to open on October 06, 2017 with Price Band of ₹456 to ₹459 per Equity Share each of Face Value of ₹ 10 each - Godrej Agrovet Limited’s IPO to open on 4th October, 2017 with Price Band of Rs. 450/- to Rs. 460/- per Equity Share each of Face Value of Rs. 10/- each - Vista Equity Partners Companies pledge $1 Million USD to The Akshaya Patra Foundation to deliver millions of meals to Indian school children - Trailer of ISIS- Enemies of Humanity Launched at World One Music Festival - RankHigher Adds Another Feather In It's Cap With The Prestigious Big Bang Award 2017,Boosts Awareness On Organ Donation - Concept PR Bags The Prestigious Fulcrum Award - PAWA INVITED IN BERLIN ON WORLD PEACE DAY FOR HIS MELODIOUS MUSICAL CONCERT "SAMBUDDHA LIVE"
  Print Print |  E-mail

Eris Lifesciences Limited – IPO to open on 16 June, 2017, and to close on 20th June, 2017 : Price Band fixed from Rs. 600 to Rs. 603 per Equity Share

(From L-R) – Mr Arvind Vashistha, Citigroup Global Markets India, Mr Chirag Negandhi, Axis Capital Limited, Mr Amit Bakshi, Chairman and Managing Director, Eris Lifesciences Ltd, Mr Himanshu Shah, Executive Director, Eris Lifesciences Ltd, Sachin Shah, Chief Financial Officer, Eris Lifesciences Ltd and Mr Sumit Jalan, Credit Suisse Securities (India) Private Limited at the press conference in Mumbai to announce the IPO of Eris Lifesciences Ltd. The issue will open for subscription on Friday 16th and closes on Tuesday 20th June 2017.- Photo By Sachin Murdeshwar GNS(From L-R) – Mr Arvind Vashistha, Citigroup Global Markets India, Mr Chirag Negandhi, Axis Capital Limited, Mr Amit Bakshi, Chairman and Managing Director, Eris Lifesciences Ltd, Mr Himanshu Shah, Executive Director, Eris Lifesciences Ltd, Sachin Shah, Chief Financial Officer, Eris Lifesciences Ltd and Mr Sumit Jalan, Credit Suisse Securities (India) Private Limited at the press conference in Mumbai to announce the IPO of Eris Lifesciences Ltd. The issue will open for subscription on Friday 16th and closes on Tuesday 20th June 2017.- Photo By Sachin Murdeshwar GNS

Mumbai, June 9, 2017 (GNS) :Eris Lifesciences Limited (the “Company” or “Issuer”) proposes to open on Friday, June 16, 2017, an initial public offering of equity shares of face value of Re. 1 each (“Equity Shares”) for cash (the “Offer”) comprising of Offer For Sale of Equity Shares aggregating up to 28,875,000 Equity Shares by Selling Shareholders (“Offer For Sale”). The Bid/ Offer will close on Tuesday, June 20, 2017.

The Price Band for the Offer is fixed from Rs. 600 to Rs. 603 per Equity Share. Bids can be made for a minimum of 24 Equity Shares and in multiples of 24 Equity Shares thereafter.

The Book Running Lead Managers (“BRLMs”) to the Offer are Axis Capital Limited, Citigroup Global Markets India Private Limited and Credit Suisse Securities (India) Private Limited.

The Company and Investor Selling Shareholder may, in consultation with the BRLMs, consider participation by Anchor Investors in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 as amended (“SEBI ICDR Regulations”). The Anchor Investor Bidding Date shall be one Working Day prior to the Bid/Offer Opening Date; i.e., Thursday, June 15, 2017.

The Equity Shares offered through the RHP are proposed to be listed on BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”).

In terms of Rule 19(2)(b)(iii) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”) and in accordance with Regulation 26(2) of the SEBI ICDR Regulations, the Offer is being made through the Book Building Process, wherein 75% of the Offer shall be allocated on a proportionate basis to Qualified Institutional Buyers (“QIBs”), provided that the Company and the Investor Selling Shareholder may, in consultation with the BRLMs, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis ( “Anchor Investor Portion” ) at the Anchor Investor Allocation Price, out of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price, in accordance with the SEBI ICDR Regulations. 5% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Price. Further, not more than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not more than 10% of the Offer shall be available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. All potential investors, other than Anchor Investors, are required to mandatorily use the Application Supported by Blocked Amount (“ASBA”) process providing details of their respective bank accounts which will be blocked by the Self Certified Syndicate Banks (“SCSBs”) to participate in the Offer. For details, see “Offer Procedure” on Page 292 of the Red Herring Prospectus dated June 6, 2017 (“RHP”).ENDS. 

For more information, visit Eris Lifesciences Limited at http://www.eris.co.in